Skip to main content
Top
Published in: BMC Neurology 1/2017

Open Access 01-12-2017 | Case report

Early Onset Parkinson’s Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report

Authors: Brendan P. Norman, Steven J. Lubbe, Manuela Tan, Naomi Warren, Huw R. Morris

Published in: BMC Neurology | Issue 1/2017

Login to get access

Abstract

Background

Bi-allelic mutations in the genes Parkin (PARK2), PINK1 (PARK6) and DJ-1 (PARK7) are established causes of autosomal recessive early-onset Parkinson’s Disease (EOPD). PINK1 mutations are the second commonest cause of EOPD. Specific mutations may be relatively common in certain populations because of a founder effect. Homozygous p.A217D PINK1 mutations were previously shown to cause EOPD in a large Sudanese kindred.

Case presentation

Here we report the segregation of homozygous PINK1 p.A217D mutations in a family originating in Morocco with a history of parental consanguinity. From the clinical information available for the index case, the phenotype of mild, slowly-progressive Parkinsonism is consistent with previous reports of p.A217D disease and of PINK1 disease phenotype more generally. The reported features of early prominent lower-limb symptoms and gait disturbance with asymmetrical onset are more frequent among PINK1 disease cases.

Conclusions

Together, reports of p.A217D in families of Moroccan and Sudanese origin suggest that p.A217D is a North African mutation due to a founder effect. Wider genetic analyses of EOPD in North Africa would be useful to estimate the prevalence of Parkinsonism caused by PINK1 p.A217D. In the absence of bi-allelic Parkin mutations, PINK1 mutations should be considered in cases with evidence of autosomal recessive inheritance of EOPD and presentation of atypical features such as early lower-limb symptoms and gait disturbance with asymmetrical onset, which appear to be common in Mendelian EOPD.
Literature
1.
2.
go back to reference Cornford ME, Chang L, Miller BL. The neuropathology of parkinsonism: an overview. Brain Cogn. 1995;28(3):321–41.CrossRefPubMed Cornford ME, Chang L, Miller BL. The neuropathology of parkinsonism: an overview. Brain Cogn. 1995;28(3):321–41.CrossRefPubMed
3.
go back to reference Thacker EL, Ascherio A. Familial aggregation of Parkinson’s disease: a meta-analysis. Mov Disord. 2008;23(8):1174–83.CrossRefPubMed Thacker EL, Ascherio A. Familial aggregation of Parkinson’s disease: a meta-analysis. Mov Disord. 2008;23(8):1174–83.CrossRefPubMed
4.
go back to reference Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MDW, Misbahuddin A, et al. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease. Mov Disord. 2012;27(12):1522–9.CrossRefPubMed Kilarski LL, Pearson JP, Newsway V, Majounie E, Knipe MDW, Misbahuddin A, et al. Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson’s disease. Mov Disord. 2012;27(12):1522–9.CrossRefPubMed
7.
go back to reference Arena G, Valente EM. PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease. J Pathol. 2017;241(2):251–63.CrossRefPubMed Arena G, Valente EM. PINK1 in the limelight: multiple functions of an eclectic protein in human health and disease. J Pathol. 2017;241(2):251–63.CrossRefPubMed
8.
go back to reference Lesage S, Brice A. Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009;18(R1):R48–59.CrossRefPubMed Lesage S, Brice A. Parkinson’s disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet. 2009;18(R1):R48–59.CrossRefPubMed
9.
go back to reference Puschmann A. Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord. 2013;19(4):407–15.CrossRefPubMed Puschmann A. Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord. 2013;19(4):407–15.CrossRefPubMed
10.
go back to reference Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRefPubMed Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–70.CrossRefPubMed
11.
12.
go back to reference Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695–9.CrossRefPubMed
13.
go back to reference Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.CrossRefPubMed Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–98.CrossRefPubMed
14.
go back to reference Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res. 1982;17(1):37–49.
15.
go back to reference Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.CrossRefPubMed Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540–5.CrossRefPubMed
16.
go back to reference Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed
17.
go back to reference Chaudhuri KR, Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21(7):916–23.CrossRefPubMed Chaudhuri KR, Martinez-Martin P, Schapira AHV, Stocchi F, Sethi K, Odin P, et al. International multicenter pilot study of the first comprehensive self-completed nonmotor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord. 2006;21(7):916–23.CrossRefPubMed
19.
go back to reference McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.CrossRefPubMedPubMedCentral McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297–303.CrossRefPubMedPubMedCentral
20.
go back to reference Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRefPubMedPubMedCentral Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.CrossRefPubMedPubMedCentral
22.
23.
go back to reference Adzhubei I a, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9.CrossRefPubMedPubMedCentral Adzhubei I a, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9.CrossRefPubMedPubMedCentral
25.
go back to reference Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–6.CrossRefPubMed Schwarz JM, Rödelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575–6.CrossRefPubMed
26.
go back to reference Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6(12):e1001025.CrossRefPubMedPubMedCentral Davydov EV, Goode DL, Sirota M, Cooper GM, Sidow A, Batzoglou S. Identifying a high fraction of the human genome to be under selective constraint using GERP++. PLoS Comput Biol. 2010;6(12):e1001025.CrossRefPubMedPubMedCentral
27.
go back to reference Leutenegger A-L, Salih MAM, Ibáñez P, Mukhtar MM, Lesage S, Arabi A, et al. Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1. Arch Neurol. 2006;63(9):1257–61.CrossRefPubMed Leutenegger A-L, Salih MAM, Ibáñez P, Mukhtar MM, Lesage S, Arabi A, et al. Juvenile-onset Parkinsonism as a result of the first mutation in the adenosine triphosphate orientation domain of PINK1. Arch Neurol. 2006;63(9):1257–61.CrossRefPubMed
28.
go back to reference Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.CrossRefPubMedPubMedCentral Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–91.CrossRefPubMedPubMedCentral
29.
go back to reference Bonifati V, Rohé CF, Breedveld GJ, Fabrizio E, De Mari M, Tassorelli C, et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology. 2005;65(1):87–95.CrossRefPubMed Bonifati V, Rohé CF, Breedveld GJ, Fabrizio E, De Mari M, Tassorelli C, et al. Early-onset parkinsonism associated with PINK1 mutations: frequency, genotypes, and phenotypes. Neurology. 2005;65(1):87–95.CrossRefPubMed
30.
go back to reference Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet. 2001;68(4):895–900.CrossRefPubMedPubMedCentral Valente EM, Bentivoglio AR, Dixon PH, Ferraris A, Ialongo T, Frontali M, et al. Localization of a novel locus for autosomal recessive early-onset parkinsonism, PARK6, on human chromosome 1p35-p36. Am J Hum Genet. 2001;68(4):895–900.CrossRefPubMedPubMedCentral
31.
go back to reference Hatano Y, Sato K, Elibol B, Yoshino H, Yamamura Y, Bonifati V, et al. PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations. Neurology. 2004;63(8):1482–5.CrossRefPubMed Hatano Y, Sato K, Elibol B, Yoshino H, Yamamura Y, Bonifati V, et al. PARK6-linked autosomal recessive early-onset parkinsonism in Asian populations. Neurology. 2004;63(8):1482–5.CrossRefPubMed
32.
go back to reference Ibáñez P, Lesage S, Lohmann E, Thobois S, De Michele G, Borg M, et al. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain. 2006;129(3):686–94.CrossRefPubMed Ibáñez P, Lesage S, Lohmann E, Thobois S, De Michele G, Borg M, et al. Mutational analysis of the PINK1 gene in early-onset parkinsonism in Europe and North Africa. Brain. 2006;129(3):686–94.CrossRefPubMed
33.
go back to reference Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(5):585–9.CrossRefPubMedPubMedCentral Burn DJ, Rowan EN, Allan LM, Molloy S, O’Brien JT, McKeith IG. Motor subtype and cognitive decline in Parkinson’s disease, Parkinson’s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2006;77(5):585–9.CrossRefPubMedPubMedCentral
34.
go back to reference Samaranch L, Lorenzo-Betancor O, Arbelo JM, Ferrer I, Lorenzo E, Irigoyen J, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain. 2010;133(4):1128–42.CrossRefPubMed Samaranch L, Lorenzo-Betancor O, Arbelo JM, Ferrer I, Lorenzo E, Irigoyen J, et al. PINK1-linked parkinsonism is associated with Lewy body pathology. Brain. 2010;133(4):1128–42.CrossRefPubMed
35.
go back to reference Ephraty L, Porat O, Israeli D, Cohen OS, Tunkel O, Yael S, et al. Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations. Mov Disord. 2007;22(4):566–9.CrossRefPubMed Ephraty L, Porat O, Israeli D, Cohen OS, Tunkel O, Yael S, et al. Neuropsychiatric and cognitive features in autosomal-recessive early parkinsonism due to PINK1 mutations. Mov Disord. 2007;22(4):566–9.CrossRefPubMed
36.
go back to reference Marongiu R, Ferraris A, Ialongo T, Michiorri S, Soleti F, Ferrari F, et al. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum Mutat. 2008;29(4):565.CrossRefPubMed Marongiu R, Ferraris A, Ialongo T, Michiorri S, Soleti F, Ferrari F, et al. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Hum Mutat. 2008;29(4):565.CrossRefPubMed
37.
go back to reference Fiorio M, Valente EM, Gambarin M, Bentivoglio AR, Ialongo T, Albanese A, et al. Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. J Neurol. 2008;255(9):1372–7.CrossRefPubMed Fiorio M, Valente EM, Gambarin M, Bentivoglio AR, Ialongo T, Albanese A, et al. Subclinical sensory abnormalities in unaffected PINK1 heterozygotes. J Neurol. 2008;255(9):1372–7.CrossRefPubMed
38.
go back to reference Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Laruffa M, et al. Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord. 2009;24(16):2350–7.PubMed Ferraris A, Ialongo T, Passali GC, Pellecchia MT, Brusa L, Laruffa M, et al. Olfactory dysfunction in Parkinsonism caused by PINK1 mutations. Mov Disord. 2009;24(16):2350–7.PubMed
39.
go back to reference Kertelge L, Brüggemann N, Schmidt A, Tadic V, Wisse C, Dankert S, et al. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Mov Disord. 2010;25(15):2665–9.CrossRefPubMed Kertelge L, Brüggemann N, Schmidt A, Tadic V, Wisse C, Dankert S, et al. Impaired sense of smell and color discrimination in monogenic and idiopathic Parkinson’s disease. Mov Disord. 2010;25(15):2665–9.CrossRefPubMed
40.
go back to reference Eggers C, Schmidt A, Hagenah J, Brüggemann N, Klein JC, Tadic V, et al. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit. Neurology. 2010;74(22):1798–805.CrossRefPubMed Eggers C, Schmidt A, Hagenah J, Brüggemann N, Klein JC, Tadic V, et al. Progression of subtle motor signs in PINK1 mutation carriers with mild dopaminergic deficit. Neurology. 2010;74(22):1798–805.CrossRefPubMed
41.
go back to reference Ricciardi L, Petrucci S, Guidubaldi A, Ialongo T, Serra L, Ferraris A, et al. Phenotypic variability of PINK1 expression: 12 Years’ clinical follow-up of two Italian families. Mov Disord. 2014;29(12):1561–6.CrossRefPubMed Ricciardi L, Petrucci S, Guidubaldi A, Ialongo T, Serra L, Ferraris A, et al. Phenotypic variability of PINK1 expression: 12 Years’ clinical follow-up of two Italian families. Mov Disord. 2014;29(12):1561–6.CrossRefPubMed
42.
go back to reference Reetz K, Lencer R, Steinlechner S, Gaser C, Hagenah J, Büchel C, et al. Limbic and frontal cortical degeneration is associated with psychiatric symptoms in PINK1 mutation carriers. Biol Psychiatry. 2008;64(3):241–7.CrossRefPubMed Reetz K, Lencer R, Steinlechner S, Gaser C, Hagenah J, Büchel C, et al. Limbic and frontal cortical degeneration is associated with psychiatric symptoms in PINK1 mutation carriers. Biol Psychiatry. 2008;64(3):241–7.CrossRefPubMed
43.
go back to reference Steinlechner S, Stahlberg J, Völkel B, Djarmati A, Hagenah J, Hiller A, et al. Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations. J Neurol Neurosurg Psychiatry. 2007;78(5):532–5.CrossRefPubMedPubMedCentral Steinlechner S, Stahlberg J, Völkel B, Djarmati A, Hagenah J, Hiller A, et al. Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations. J Neurol Neurosurg Psychiatry. 2007;78(5):532–5.CrossRefPubMedPubMedCentral
44.
go back to reference Rogaeva E, Johnson J, Lang AE, Gulick C, Gwinn-Hardy K, Kawarai T, et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol. 2004;61(12):1898–904.CrossRefPubMed Rogaeva E, Johnson J, Lang AE, Gulick C, Gwinn-Hardy K, Kawarai T, et al. Analysis of the PINK1 gene in a large cohort of cases with Parkinson disease. Arch Neurol. 2004;61(12):1898–904.CrossRefPubMed
Metadata
Title
Early Onset Parkinson’s Disease in a family of Moroccan origin caused by a p.A217D mutation in PINK1: a case report
Authors
Brendan P. Norman
Steven J. Lubbe
Manuela Tan
Naomi Warren
Huw R. Morris
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Neurology / Issue 1/2017
Electronic ISSN: 1471-2377
DOI
https://doi.org/10.1186/s12883-017-0933-z

Other articles of this Issue 1/2017

BMC Neurology 1/2017 Go to the issue